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Abstract
Introduction: Estimation of the glomerular filtration rate (GFR) is essential for the evaluation of
patients with kidney disease, and for treating patients with drugs that are eliminated from the
circulation by the kidneys. Cystatin C has been shown to be superior to creatinine for estimating
GFR in several studies. However, studies showing that thyroid function has an impact on cystatin
C have not addressed the question of whether the changes in cystatin C levels are due to changes
in GFR or in cystatin C synthesis.
Case presentation: We report an account of a hyperthyroid patient with a discrepancy between
the GFR estimates from cystatin C and creatinine. The cystatin C concentration (1.36 mg/L) was
higher and gave an estimated GFR which was lower (51 mL/min/1.73 m2), while the creatinine
concentration was lower (36 µmol/L) and gave a corresponding creatinine-estimated GFR that was
higher (145 mL/min/1.73 m2) than the iohexol-estimated GFR (121 mL/min/1.73 m2) during the
hyperthyroid period. After thyroidectomy, the creatinine concentration was 36 µmol/L and
creatinine-estimated GFR was calculated as 73 mL/min/1.73 m2, while the cystatin C concentration
and cystatin C-calculated GFR was 0.78 mg/L and 114 mL/min/1.73 m2, respectively.
Conclusion: In contrast to creatinine, cystatin C levels rose in the hyperthyroid state as compared
to the euthyroid state. The cystatin C-estimated GFR was reduced compared to the iohexol-
estimated GFR. This patient case shows that the hyperthyroid-associated changes in cystatin C
levels are not due to changes in GFR. Thyroid function should thus be considered when both
cystatin C and creatinine are used as markers of kidney function.
Introduction
Glomerular filtration rate (GFR) is generally accepted as the
best overall indicator of renal function and is therefore an
important marker for renal disease. Reduced GFR influ-
ences the clearance of many pharmaceuticals used today. In
the last decades, serum or plasma creatinine has become
the most commonly used marker for estimating GFR in
clinical practice [1,2]. Despite common use, creatinine has
serious limitations as a marker for renal function. GFR is
often calculated from plasma creatinine using the Cock-
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croft-Gault [3] or Modification of Diet in Renal Disease
(MDRD) study equations [4]. It is recommended that lab-
oratories should report estimated GFR instead of only
reporting the concentration of the analyte [5]. Creatinine is
also influenced by factors such as age, gender, muscle mass,
thyroid function and physical activity [6]. Cystatin C is a
cysteine protease inhibitor with a molecular mass of 13
kDa [7]. A recent meta-analysis indicated that cystatin C is
superior to plasma creatinine as a marker for estimating
renal function [8]. Serum cystatin C concentration is
reported to be unaffected by muscle mass, age, inflamma-
tion, fever or exogenous agents [9,10]. However, there are
reports that thyroid function has an impact on both cysta-
tin C and creatinine levels [11]. Serum creatinine values
have been shown to be higher in hypothyroidism, and
lower in hyperthyroidism, as compared to the euthyroid
state. For cystatin C levels, the contrary was reported in
these patient groups [12]. These cystatin C alterations are
probably due to changes in the synthesis of cystatin C, but
could also be due to changes in clearance as suggested for
creatinine. There are no reports on the correlation between
cystatin C alterations in hyperthyroid patients and GFR
measured with an exogenous marker. Thus, in a hyperthy-
roid patient, we compared cystatin C with iohexol clear-
ance.
Case presentation
Case description
A Caucasian female (age 25), smoker, was admitted to the
emergency unit with symptoms of tachycardia and anxiety.
Thyroid tests were ordered on suspicion of hyperthy-
roidism. The test results showed values characteristic of
severe hyperthyroidism: TSH was below the detection limit
of the assay (<0.001 mU/L), 40 pmol/L free T4 (ref. interval
10–18 pmol/L) and 6.4 nmol T3/L (ref. interval 1.2–2.8
nmol/L). Antibody levels against thyroid peroxidase (anti-
TPO) and TSH receptor were increased as follows: 29 kIU
anti-TPO/L (ref. interval <16) and 11 anti-TSH receptor U/
L (ref. interval <0.6 U/L). The patient was diagnosed with
Graves's disease showing disseminated thyroid enlarge-
ment. Initial treatment included a β-receptor blocker, pro-
pranolol and an inhibitor of thyroxin synthesis called
timazol. Later, a thyroidectomy was performed.
Plasma levels of creatinine and cystatin C were analyzed as
markers of kidney function. When the patient was in the
hyperthyroid state, plasma creatinine was 36 µmol/L (ref.
interval 50–90 µmol/L) and cystatin C was 1.36 mg/L. Cal-
culated glomerular filtration rate (GFR) from creatinine
was 145 mL/min/1.73 m2 according to the bias-corrected
MDRD equation [13] and 51 mL/min/1.73 m2 as calcu-
lated from cystatin C [14]. A subsequent iohexol clearance
was performed two days later due to the disproportion
between the two GFR estimations. The GFR determined by
iohexol clearance during the hyperthyroid period was 121
mL/min/1.73 m2.
Six months later (after surgery), the patient was clinically
euthyroid with a TSH value of 3.69 mIE/L and 15 pmol free
T4/L. Creatinine and cystatin C levels were 65 µmol/L and
0.78 mg/L, respectively. GFR-calculated from the creatinine
concentration was 73 mL/min/1.73 m2 compared to 114
mL/min/1.73 m2 using the cystatin C concentration.
GFR was determined by measuring the plasma clearance of
iohexol, an x-ray contrast agent that is a reliable marker for
GFR. The patient was given 5 mL iohexol solution (Omni-
paque, Nycomed Amersham) intravenously in an antecu-
bital vein. The GFR was calculated from the iohexol
concentration after the injection. Serum iohexol levels were
determined by high-pressure liquid chromatography. The
total analytical imprecision of the method was 2.5% using
a control sample with an assigned value of 33.5 mg/L and
2.4% for a control sample with an assigned value of 65.7
mg/L.
Plasma creatinine measurements were performed by means
of the modified kinetic Jaffe reaction on an Architect ci8200
analyzer (Abbott Laboratories, Abbott Park, IL, USA) and
reported using S.I. units (µmol/L). The total analytical
imprecision of the creatinine method was 3.2% both at 94
and 337 µmol/L.
Cystatin C immunoparticles (code 1014), assay buffer
(code 1007), calibrator (code 1012) and control set (code
1019) were all obtained from Gentian (Moss, Norway).
The immunoparticles are coated with purified chicken anti-
bodies to cystatin C on uniform polystyrene particles.
Plasma cystatin C measurements on the Architect ci8200
was performed using the following instrument settings: pri-
mary wavelength 548 nm, secondary wavelength 700 nm,
sample blank position 18, and spline calibration method.
220 µL reagent 1 and 3 µL sample were mixed with 45 µL
reagent 2. The total analytical imprecision of the cystatin C
method was 1.7% at 0.77 mg/L, 1.1% at 1.25 mg/L and
1.4% at 5.45 mg/L.
TSH, free T4 and T3 were also analyzed using the Architect
ci8200. The measuring range of the TSH method was
0.001–100 mU/L. The total analytical imprecision of the
TSH method was 2.4% at 0.52 mU/L and 2.4% at 5.07 mU/
L. The total analytical imprecision was 7.7% at 0.81 nmol/
L and 2.53% at 4.06 nmol/L for the T3 method, and 5.2%
at 11.5 pmol/L and 4.4% at 16.8 pmol/L for the free T4
method.
Anti-TPO was analyzed on a Liaison instrument (DiaSorin
Laboratories, Saluggia, Italy). The total analytical impreci-
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8.1% at 161.8 kU/L. Anti-TSH receptor antibodies were
analyzed with an ELISA kit from RSR Ltd. (Cardiff, United
Kingdom).
Discussion
Hypo- and hyperthyroid diseases occur frequently. Hence,
it is important to be aware of erroneous results due to these
diseases. The cystatin C-estimated GFR (51 mL/min/1.73
m2) during the hyperthyroid period was lower than the cor-
responding iohexol-estimated GFR (121 mL/min/1.73
m2). On the other hand, the cystatin C-estimated GFR post-
operatively (114 mL/min/1.73 m2) was in close agreement
with the iohexol-estimated GFR during the hyperthyroid
period. This indicates that the increase in cystatin C and
subsequent decrease in cystatin C-estimated GFR is not due
to a change in glomerular clearance, but rather due to an
increased synthesis related to the hyperthyroid state. Cysta-
tin C is considered to be produced in all nucleated cells at a
constant rate. No iohexol clearance was performed in the
euthyroid state. The iohexol clearance performed during
the hyperthyroid state was part of the patient's treatment to
evaluate whether the patient had a decreased GFR or not.
During the euthyroid state, the cystatin C-estimated GFR
was 114 mL/min/1.73 m2 and the creatinine-estimated
GFR was 73 mL/min/1.73 m2. According to previous
reports, the MDRD equation should only be used to report
numeric results below 60 mL/min/1.73 m2 [15]. Thus, both
GFR estimates in the euthyroid period were considered nor-
mal, and it was therefore not considered ethical to perform
an additional iohexol clearance during the euthyroid
period.
The creatinine values (36 µmol/L) in this patient were
reduced during the hyperthyroid period with an ensuing
catabolic state resulting in an overestimation of the creati-
nine-calculated GFR (145 mL/min/1.73 m2). Thus, both
cystatin C and creatinine gave erroneous GFRs in compari-
son to iohexol clearance, which was used as the reference
method.
Conclusion
The alteration in cystatin C level is not due to a change in
GFR in connection with hyperthyroidism. Accordingly,
altered thyroid function should be considered both when
creatinine and cystatin C is used for determining kidney
function.
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